EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genoray Co's enterprise value is ₩89,300 Mil.
Genoray Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩103,605 Mil. Therefore, Genoray Co's EV-to-Revenue for today is 0.86.
The historical rank and industry rank for Genoray Co's EV-to-Revenue or its related term are showing as below:
XKRX:122310'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.83 Med: 1.77 Max: 7.45
Current: 0.86
During the past 13 years, the highest EV-to-Revenue of Genoray Co was 7.45. The lowest was 0.83. And the median was 1.77.
XKRX:122310's EV-to-Revenue is ranked better than 84.23% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.21
vs XKRX:122310: 0.86
As of today (2024-05-28), Genoray Co's stock price is ₩6410.00.
Genoray Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩7,627.21. Therefore, Genoray Co's PS Ratio for today is 0.84.
Genoray Co EV-to-Revenue Historical Data
The historical data trend for Genoray Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Genoray Co's EV-to-Revenue
For the Diagnostics & Research subindustry, Genoray Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genoray Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genoray Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Genoray Co's EV-to-Revenue falls into.
Genoray Co's current Enterprise Value is ₩89,300 Mil.
Genoray Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩103,605 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genoray Co (XKRX:122310) EV-to-Revenue Explanation
Genoray Co's share price for today is ₩6410.00.
Genoray Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,627.21.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genoray Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Genoray Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Genoray Co Ltd manufactures and sells medical and dental systems in South Korea. The company has developed the 3DCT software for medical and dental applications and developed innovative 3D software for dentistry. The product portfolio includes OSCAR prime, ZEN-7000, MX-600, PORT-X II, PORT-X IV, and PAPAYA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:122310 has been successfully added to your 